The DOI matches its Crossref record; 363 of the 363 references it cites were found in a registry or an index.
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy
Open accessAbstract
The potential of alpha-particle emitters to treat cancer has been recognized since the early 1900s. Advances in the targeted delivery of radionuclides and radionuclide conjugation chemistry, and the increased availability of alpha-emitters appropriate for clinical use, have recently led to patient trials of radiopharmaceuticals labeled with alpha-particle emitters. Although alpha-emitters have been studied for many decades, their current use in humans for targeted therapy is an important milestone. The objective of this work is to review those aspects of the field that are pertinent to targeted alpha-particle emitter therapy and to provide guidance and recommendations for human alpha-particle emitter dosimetry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Although b - and g -radiation are viewed as having a relative biologic ef fi ciency (RBE) of 1.0, other emerging RPTs, particularly those that use radionuclides that emit a -particles, carry much a higher RBE ( 21 ).”
From Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns (2021) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE STOPPING AND RANGE OF IONS IN SOLIDS
Ziegler, J. F. (1988) · Elsevier eBooks · doi:10.1016/b978-0-12-780621-1.50005-8 · Cited by 9,077
THE STOPPING AND RANGE OF IONS IN SOLIDS
Ziegler, J. F. (1984) · Elsevier eBooks · doi:10.1016/b978-0-12-780620-4.50007-0 · Cited by 5,892
Recommendations of the International Commission on Radiological Protection
(1961) · Postgraduate Medical Journal · doi:10.1136/pgmj.37.425.168-b · Cited by 5,868
The Stopping and Range of Ions in Matter
Ziegler, J. F., & Biersack, J. P. (1985) · Springer eBooks · doi:10.1007/978-1-4615-8103-1_3 · Cited by 4,360
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
The Stopping and Ranges of Ions in Matter
(1980) · Elsevier eBooks · doi:10.1016/c2013-0-02882-4 · Cited by 3,012
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,228
International Commission on Radiological Protection
(1969) · Radiology · doi:10.1148/93.6.1298 · Cited by 2,148
Basic anatomical and physiological data for use in radiological protection: reference values
Valentin, J. (2002) · Annals of the ICRP · doi:10.1016/s0146-6453(03)00002-2 · Cited by 2,024
Report of the task group on reference man
(1979) · Annals of the ICRP · doi:10.1016/0146-6453(79)90123-4 · Cited by 1,715
Research works printed but not linked: 32
- 2005, J Nucl Med., 46, 199S
- 1990, Antibody Immunoconjugates Radiopharm., 4, 85
- 1997, Blood., 90, 2245
- 2006, Cancer Biother Radiopharm., 21, 395
- 2006, Cancer Biother Radiopharm., 21, 396
- 2006, J Nucl Med., 47, 1049
- International Commission on Radiological Protection. Relative Biological Effectiveness (RBE), Quality Factor (Q), and Radiation Weighting Factor (wR). Philadelphia, PA: Elsevier; 2004. ICRP publication 92.
- 1964, Cancer Res., 24, 683
- 1995, J Nucl Med., 36, 259
- 1989, Lancet., 2, 650
- 1997, J Nucl Med., 38, 727
- 2000, J Nucl Med., 41, 941
- 2007, Ann ICRP., 37, 1
- 1994, J Nucl Med., 35, 521
- 1993, J Nucl Med., 34, 1811
- 1988, Cancer Res., 48, 7022
- 1992, J Nucl Med., 33, 2167
- 1994, J Nucl Med., 35, 303
- Fisher DR. The microdosimetry of monoclonal antibodies labeled with alpha emitters. In: Schlafke-Stelson AT, Watson EE, eds. Fourth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN: Oak Ridge Associated Universities; 1986:26–36.
- Kellerer AM. Analysis of patterns of energy deposition: a survey of theoretical relations in microdosimetry. In: Ebert HG, ed. Proceedings of the Second Symposium on Microdosimetry. Brussels, Belgium: Commission of European Communities; 1970:107–134.
- 1997, J Nucl Med., 38, 1923
- 2004, J Nucl Med., 45, 129
- 2001, J Nucl Med., 42, 1216
- 1999, J Nucl Med., 40, 37S
- 1975, J Nucl Med., 16, 248
- 1999, J Nucl Med., 40, 1935
- 2002, J Nucl Med., 43, 97
- 2003, J Nucl Med., 44, 774
- 2005, J Nucl Med., 46, 1171
- 1969, J Nucl Med., 10, 7
- 1999, J Nucl Med., 40, 1947
- Goodhead DT. Talk 23, Alpha Emitters, from Session 6, Effects from Specific Sources of Internal Radiation. Presented at: CERRIE Workshop; July 21–23, 2003; Oxford, U.K.
Cited by
Sorted by citations
Items 501–570 of 570
Antibody Based Radiopharmaceuticals in Clinical Development
Mithun, S., Chitnis, K., Shetye, B., Kameswaran, M., Jha, A. K., & Rangarajan, V. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677139-00257
Koniar, H., & Schaffer, P. C. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837677139-00056
Deep learning-based segmentation of Jaszczak ACR phantom images for optimized Radium-223 dosimetry
Griebler, C. F., Cordeiro, L. P., Lima, L. F. C., Bolzan, V., Dutra, V., de Sá, L. V., & Bonifácio, D. A. B. (2025) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2025.113028
Zhukovsky, M. V., Онищенко, А. Д., Barabanov, D., & Vasilyeva, D. (2025) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2025.113118
Wang, L., Song, L., Dai, X., & Hou, X. (2025) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-025-10243-7
Helium 4He nuclei based radiotherapy
Knake, N., Prokopowicz, R., Gryziński, M. A., & Kocik, J. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.112068
Impact of Alpha-Radiotherapy on the Tumor Microenvironment
Allard, M., Perrin, J., Guilloux, Y., Kraeber‐Bodéré, F., Chérel, M., & Gaschet, J. (2025) · Springer eBooks · doi:10.1007/978-3-032-00761-2_116
Korotinsky, Y., & Arazi, L. (2026) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ae5d7e
A Broadband Ultrasensitive Gamma Imager (BUGI) Technology for Simultaneous PET-SPECT Imaging
Cai, L., Aggarwal, S., Chen, Y., Komarov, S., Thorek, D. L. J., Jha, A. K., & Tai, Y. (2025) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nss/mic/rtsd57106.2025.11287503
Evaluation of the feasibility of in vivo Ac-225 imaging
Du, S. (2023) · eScholarship (California Digital Library) · doi:10.13140/rg.2.2.34500.40325
Diffusing alpha particles radiation treatment optimization in clinical settings
Feliciani, G. (2024) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/11108
Ukon, N., Zhao, S., Washiyama, K., Oriuchi, N., Tan, C., Shimoyama, S., Aoki, M., Kubo, H., Takahashi, K., & Ito, H. (2020) · Figshare · doi:10.6084/m9.figshare.12991801
Rumiantcev, M., Li, W. B., Lindner, S., Liubchenko, G., Resch, S., Bartenstein, P., Ziegler, S. I., Böning, G., & Delker, A. (2023) · Figshare · doi:10.6084/m9.figshare.24124029
Josefsson, A., Cortez, A. G., Rajkumar, H., Latoche, J. D., Jaswal, A. P., Day, K. E., Zarisfi, M., Rigatti, L. H., Huang, Z., & Nedrow, J. R. (2023) · Figshare · doi:10.6084/m9.figshare.23949715
Höllriegl, V., Petoussi-Henss, N., Hürkamp, K., Ramos, J. C. O., & Li, W. B. (2021) · Figshare · doi:10.6084/m9.figshare.14722104
Tranel, J., Palm, S., Graves, S. A., Feng, F. Y.-C., & Hope, T. A. (2022) · Figshare · doi:10.6084/m9.figshare.21256702
Self-citationMellhammar, E., Dahlbom, M., Timmermand, O. V., & Strand, S.-E. (2022) · Figshare · doi:10.6084/m9.figshare.20342373
Babeker, H. (2023) · HARVEST (University of Saskatchewan)
Smith, K., Laurie, F., Iandoli, M., Jodoin, M. B., Ding, L., Santos, J. S., & FitzGerald, T. J. (2025) · Medical Research Archives · doi:10.18103/mra.v13i10.7025
Italia, M., Bordel-Vozmediano, S., Otero, J. G., Calvo, G. F., & Pérez‐García, V. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.694859
Tikum, A. F., Fon, D. A., Njotu, F. N., Henning, N. W., Nwangele, E., Babeker, H., Ketchemen, J. P., Doroudi, A., Uppalapati, M., & Fonge, H. (2026) · Breast Cancer Research · doi:10.1186/s13058-026-02220-z
Hvass, L., Müller, M., Shalgunov, V., Clausen, A. S., Poulie, C. B. M., Aneheim, E., Jensen, H. J., Herth, M. M., & Kjær, A. (2026) · EJNMMI Research · doi:10.1186/s13550-026-01378-z
Clinical Dosimetry Models and Pathway to Integration in Routine Nuclear Medicine Practice
Akerele, M. I., Singh, B., Mikell, J., Kaur, K., Prasad, V., & Laforest, R. A. (2026) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000006180
CD20-Targeted α-Radionuclides Synergize with Immune Checkpoint Inhibition to Treat Murine Lymphoma
O’Steen, S., Lee, S. Y., Comstock, M., Kehret, A. R., Lin, Y., Hamlin, D. K., Dexter, S. L., Hippe, D. S., Gooley, T. A., Wilbur, D. S., et al. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.125.270515
Performance Evaluation of Single- and Double-Layer CZT Compton Cameras for 225 Ac Imaging
Song, G., Das, B., Seo, Y., Cho, G., & Rodríguez, J. C. (2026) · IEEE Transactions on Nuclear Science · doi:10.1109/tns.2026.3663840
Huang, B., Wang, H., Wang, S., Yan, Y., Pan, J., Li, Q., Zeng, Q., & Liu, X. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6221146
Kabayama, K., & Fukase, K. (2025) · Drug Delivery System · doi:10.2745/dds.40.378
Kondo, M. (2025) · TSpace (University of Toronto)
Fongenie, B., Scott, N., Chouin, N., Denis-Bacelar, A. M., & Stevens, D. J. (2026) · EANM Innovation · doi:10.1016/j.eanmi.2026.100129
Xie, L., Hanyu, M., Fujinaga, M., Zhang, Y., Kokufuta, T., Kumata, K., Mori, W., Kazui, N., Ohkubo, T., Wakizaka, H., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.02.032
Khavari, R. A., Mirzaee, D., Azizi, N. M., & Yar, I. H. (2026) · Journal of Natural Science Review · doi:10.62810/jnsr.v4i1.302
Ladjohounlou, R. (2016) · theses.fr (ABES) · doi:10.70675/e158c078z5d25z47f5z95f5z5e772fe46a8f
Développement d'analogues urotensinergiques radiomarqués pour l'imagerie de tumeurs solides
Poret, B. (2018) · theses.fr (ABES) · doi:10.70675/bbffea07z6c9cz43f4zb871z7b6df9df9cd2
Radiothérapie interne vectorisée alpha anti-PD-L1 dans le traitement du mélanome
Capitao, M. (2020) · theses.fr (ABES) · doi:10.70675/67c42208zec1ez48bfza06fz890c05f942e7
Impact de la radiothérapie interne vectorisée alpha sur le microenvironnement tumoral
Perrin, J. (2021) · theses.fr (ABES) · doi:10.70675/31c91866z101fz4e07zbde2z6887a8fdba6d
Ketchemen, J. P., Monzer, A., Njotu, F. N., Babeker, H., Tikum, A. F., Nwangele, E., Henning, N. W., Hassani, N., Ngong, A. F., Doroudi, A., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-026-03393-2
Élaboration d’une méthodologie théorique pour l’étude de la complexation du radium(II) en solution
Mohaman, H. (2024) · theses.fr (ABES) · doi:10.70675/54b3dc4dzb50az49e2zaa68z279ad20114a3
Levrague, V. (2024) · theses.fr (ABES) · doi:10.70675/2ae48b0ez0256z40eaz9017ze11968c87fcc
Shabnam, M., Shah, S. Q., & DeryaIlem-Ozdemir (2026) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-026-01010-x
mGluR1-targeted radiotheranostics: A new framework for PET-guided α-particle therapy
Lee, S. M., Kashiwagi, S., & Kang, H. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.022
Design of a ThO2 target for actinium-225 development at IRIS
Kim, J., Park, B. S., Yeon, Y. H., Jung, H. W., Baek, B., Hong, I.-S., Yim, H.-J., Lee, J. H., & Shin, T. (2026) · Journal of the Korean Physical Society · doi:10.1007/s40042-026-01646-0
Yan, A., Zhang, J., Yao, J., Qin, S., Luan, X., Song, Z., Zhang, H., Yang, M., Yang, G., Zhang, J., et al. (2026) · Journal of Nuclear Medicine and Molecular Imaging · doi:10.65457/jnmmi-2026-0022
Lielkajis, M., Rosenfeld, A. B., Guatelli, S., Metcalfe, P. E., Poder, J., Bucci, J. A., & Cutajar, D. L. (2026) · Medical Physics · doi:10.1002/mp.70494
Kikuchi, Y., Koshikawa, N., Tanaka, R., Tanaka, K. S., Kato, H., Kadonaga, Y., Takahashi, K., Toyoshima, A., Murakami, M., Ooe, K., et al. (2026) · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · doi:10.1016/j.nima.2026.171775
Conceptual design of a mass separation system for high-purity actinium-225
Dong, Q., Li, Y., Jing, H., Wang, P., Tan, Z., Liu, J., Wang, Y., Dai, M., & Guo, Y. (2026) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2026.114190
Molecular imaging and radioligand therapies in pheochromocytomas and paragangliomas
Hernández-Félix, J. H., Golagha, M., Jha, A., Varghese, D., Grozinsky‐Glasberg, S., Riechelmann, R. P., Fazio, N., Pavel, M., Lin, F. I., Taïeb, D., et al. (2026) · Endocrine Related Cancer · doi:10.1530/erc-26-0036
Sabri, M. E., Moghaddasi, L., Wilson, P., Saran, F., & Bezak, E. (2026) · Medical Physics · doi:10.1002/mp.70566
Guth, M. A. S. (2026) · Clinical nuclear medicine open. · doi:10.1097/nm9.0000000000000092
Ibrahim, M. S., Zakaly, H. M. H., Ashour, A., Ahmed, A. A., Khalaf, H. N. B., & Mostafa, M. Y. A. (2026) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2026.114335
Normal-Organ Absorbed Dose and Response Assessment in α-Particle Radiopharmaceutical Therapy
Hesterman, J. Y., Hobbs, R. F., Kiess, A. P., Jardine, V., Sneeden, E. Y., Schwarz, J., Huntzinger, C. J., Zepeda‐Orozco, D., Sartor, O., & Sgouros, G. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.126.272179
Self-citationBabeker, H., Nwangele, E., Monzer, A., Ketchemen, J. P., Bato, K. E. M., Njotu, F. N., Tikum, A. F., Mercado, T. R., Doroudi, A., Torlakovic, E., et al. (2026) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-26-0326
Revolutionizing Internal Dosimetry with AI: PET-Only Solutions for Precision Medicine
Rathod, N. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016824
García-Arce, D., Luna‐Gutiérrez, M., Cruz-Nova, P., Limón, A. M. V., Jiménez‐Mancilla, N., Aranda‐Lara, L., Azorin‐Vega, E. P., Morales-Ávila, E., Rodríguez-López, P., Santos‐Cuevas, C., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177785
134Ce/134La Radiotheranostics from PET Surrogation of 225Ac to Auger and Conversion-Electron Therapy
Brejeon, A., Seo, Y., VanBrocklin, H. F., Flavell, R. R., & Bobba, K. N. (2026) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6c00722
Preclinical evaluation of MC1R targeted radiopharmaceuticals using the 203/212Pb theranostic pair
Scaffidi-Muta, J. M., Boucher, D., Li, K., Liu, F., Tieu, W., & Abell, A. D. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119341
Wenker, S. T. M., Franssen, G. M., Molkenboer‐Kuenen, J. D. M., Konijnenberg, M., Lobeek, D., Tamborino, G., Peters, H., van Lith, S. A. M., Heskamp, S., & Bussink, J. (2026) · Molecular Imaging and Biology · doi:10.1007/s11307-026-02142-4
Radiotherapy‐Induced Side Effects: Epidemiology, Pathogenesis, Prevention and Treatments
Ma, X., Zhang, X., Zhao, P., Yang, J., Li, Z., Han, X., Wang, Y., Cui, Z., Liu, N., & Li, M. (2026) · MedComm · doi:10.1002/mco2.71034
Theranostics in the Central Nervous System
Chen, M., Pyatigorskaya, N., Benayoun, M. D., Ponisio, M. R., Kosović, V., & Franceschi, A. M. (2026) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2026.07.015
Jokar, N., Pashazadeh, A., Juweid, M. E., Najdian, A., Jafari, E., Mottaghy, F. M., Assadi, M., & Sathekge, M. M. (2026) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2026.09.002
Sofias, A. M., Derks, Y., Bradbury, M. S., Chen, X. S., Kiessling, F., van Dam, G. M., Weber, W., & Lammers, T. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00983-3
Kim, J., Han, N., Muzammal, A., Ahn, J. H., Im, C., Kim, S., Eom, S., Kang, C. M., Kang, K., Lee, Y. J., et al. (2026) · Advanced Science · doi:10.1002/advs.78419
Zulfiqar, H., Waqas, M., & Ali, I. (2026) · RSC Advances · doi:10.1039/d6ra06959b
Interplays Between Therapeutic Radiopharmaceuticals and Tumor Microenvironment
Zhang, Y., Zhang, Y., Zhao, Y., Ma, J., Xie, X., Qi, Z., Li, Y., Fei, G., Liu, Z., & Ni, Y. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71869
Targeted Radiopharmaceuticals for Synovitis: Emerging Molecular Imaging and Theranostic Perspectives
Luna‐Gutiérrez, M., Ocampo‐García, B., Azorin‐Vega, E. P., Meléndez‐Alafort, L., & Ferro‐Flores, G. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18111403
Li, Q., 谢建, Chen, F., Li, L., & 杨传盛 (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.2007300
Lee, W., King, A. P., Baidoo, K., Adler, S., Chung, J.-Y., Nambiar, D., Fayn, S., Jacobson, O., Choyke, P. L., & Escorcia, F. E. (2026) · Journal of Nuclear Medicine · doi:10.2967/jnumed.126.273015
Metadata
- Authors
- Sgouros, G., Roeske, J. C., McDevitt, M. R., Palm, S., Allen, B. J., Fisher, D. R., Brill, A. B., Song, H., Howell, R. W., & Akabani, G.
- Affiliations
- Johns Hopkins University (US)
- Loyola University Medical Center (US)
- Memorial Sloan Kettering Cancer Center (US)
- International Atomic Energy Agency (AT)
- Pacific Northwest National Laboratory (US)
- Vanderbilt University (US)
- Rutgers, The State University of New Jersey (US)
- Texas A&M University (US)
- ORCID
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2010-01-15
- Volume
- 51
- Issue
- 2
- Pages
- 311-328
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- PMC
- PMC5680544
- OpenAlex
- W2018649196
- Cited by
- 552
- References
- 363
- Citations by year
- 2026: 60 · 2025: 58 · 2024: 50 · 2023: 54 · 2022: 50 · 2021: 50 · 2020: 39 · 2019: 34 · 2018: 44 · 2017: 17 · 2016: 21 · 2015: 10 · 2014: 25 · 2013: 11 · 2012: 16
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Nuclear Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (P50AG005136)
- National Cancer Institute (R01CA109234, R41CA117599, P30CA008748)
- National Institute of Biomedical Imaging and Bioengineering (R01EB001994)
- National Center for Research Resources (R43RR015155)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Physical Sciences › Physics and Astronomy › Radiation › Radioactivity and Radon Measurements
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- alpha-emitting radionuclides, targeted alpha therapy, radiation biology, dosimetry, radionuclide conjugation, radiopharmaceuticals, cancer therapy
- MeSH terms
- Alpha Particles, Cell Survival, Clinical Trials as Topic, Dose-Response Relationship, Radiation, Female, Humans, Male, Neoplasms, Neoplasms, Radiation-Induced, Pamphlets, Radiation-Protective Agents, Radiobiology, Radioisotopes, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Relative Biological Effectiveness, Societies, Medical, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
